International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 : 500-505 doi: 10.5281/zenodo.16436188
Original Article
An Observational Study of The Relation of Systemic Hypertension and Ocular Perfusion Pressure in Patients with Primary Open Angle Glaucoma in A Tertiary Care Centre in Mandya
 ,
Published
Dec. 30, 2024
Abstract

Purpose: To investigate the relationship between systemic hypertension, ocular perfusion pressure (OPP), and primary open angle glaucoma (POAG) in a tertiary care center in Mandya, India.

Methods: This hospital-based observational study included 60 POAG patients. Blood pressure, intraocular pressure (IOP), and other ocular parameters were measured. Mean ocular perfusion pressure (MOPP) was calculated. The association between hypertension, antihypertensive medication use, and MOPP was analyzed. Correlation and multivariate analyses were performed to identify factors associated with MOPP.

Results: Hypertensive POAG patients had significantly lower MOPP compared to non-hypertensive POAG patients (54.2 ± 5.8 mmHg vs. 60.1 ± 5.6 mmHg, P = 0.001). POAG patients on antihypertensive medication had significantly lower MOPP than those not on medication (55.8 ± 6.1 mmHg vs. 59.4 ± 5.9 mmHg, P = 0.028). MOPP was significantly correlated with systolic blood pressure (r = -0.42, P = 0.001), IOP (r = -0.56, P < 0.001), and cup-to-disc ratio (r = -0.49, P < 0.001). Multivariate analysis identified systolic blood pressure, IOP, cup-to-disc ratio, visual field mean deviation, and antihypertensive medication use as significant factors associated with MOPP.

Conclusion: Systemic hypertension and antihypertensive medication use were associated with lower MOPP in POAG patients. The findings suggest that blood pressure and OPP may play a role in the pathogenesis of POAG and highlight the importance of considering systemic factors in the management of glaucoma patients.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
944 Views
261 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved